Stroke and thrombolysis in India [1]

Neurology India

Volumn 55, Issue 2, 2007, Pages 173-

  Pandian, Jeyaraj ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; HEPARINOID; WARFARIN;

BLOOD CLOT LYSIS; DEVELOPING COUNTRY; DRUG COST; DRUG UTILIZATION; HIGH RISK PATIENT; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INDIA; LETTER; MEDICAL PRACTICE; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SENSITIVITY AND SPECIFICITY; STROKE; THROMBOCYTE COUNT;

EID: 34250337724     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: 10.4103/0028-3886.32795     Document Type: Letter

References (5)

1. Padma MV, Singh MB, Bhatia R, Srivastava A, Tripathi M, Shukla G, et al. Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: Efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India 2007;55:46-9.
2. Gottesman RF, Alt J, Wityk RJ, Llinas RH. Predicting abnormal coagulation in ischemic stroke: Reducing delay in rtPA use. Neurology 2006;67:1665-7.
3. Pandian JD, Kalra G, Jaison A, Deepak SS, Shamsher S, Singh YP, et al. Factors delaying admission to a hospital-based stroke unit in India. J Stroke Cerebrovasc Dis 2006;15:81-7.
4. Pandian JD, Sethi V, Dhillon R, Kaur R, Padala S, Chakravorty R, et al. Is intravenous thrombolysis feasible in a developing country? Cerebrovasc Dis 2005;20:134-6.
5. Chen OT. Intravenous thrombolysis with Urokinase for acute cerebral infarctions. Hong Kong Med J 2001;7:7.